Kanagawa, Japan

Shinichi Imamura

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 81(Granted Patents)


Location History:

  • Osaka, JP (2001 - 2008)
  • Ibaraki, JP (2011 - 2012)
  • Tsukuba, JP (2011 - 2013)
  • Fujisawa, JP (2019 - 2022)
  • Kanagawa, JP (2014 - 2024)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):

Title: The Innovative Contributions of Shinichi Imamura

Introduction: Shinichi Imamura, based in Kanagawa, Japan, is a prolific inventor with a remarkable portfolio of 24 patents. His innovative work predominantly focuses on the development of compounds with significant therapeutic potential, particularly in the field of cancer treatment.

Latest Patents: Among his recent patents, Imamura has developed a heterocyclic compound that exhibits the ability to inhibit MALT1. This compound is anticipated to be valuable as both a prophylactic and therapeutic drug for cancer and other related conditions. The patent outlines a compound represented by a specific formula, emphasizing its various forms, including salts, cocrystals, hydrates, or solvates.

Career Highlights: Imamura has made significant contributions to the pharmaceutical industry through his work at esteemed companies such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His tenure at these organizations has allowed him to focus on advancing medicinal chemistry and enhance drug development processes.

Collaborations: Throughout his career, Imamura has collaborated with notable colleagues including Takaharu Hirayama and Takuto Kojima. These partnerships have facilitated the exchange of ideas and innovation, driving the development of effective pharmaceutical solutions.

Conclusion: Shinichi Imamura's contributions to the field of pharmaceuticals are marked by his substantial patent portfolio and his commitment to advancing cancer treatment through innovative compounds. His work continues to impact the industry positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…